"The definition of HIPP (American Kidney Fund's Health Insurance Payment Program) is unusually subjective, depending largely on whether you provide or receive dialysis, or insure those who undergo it.
To the former, the AKF and dialysis clinics–especially the larger chains–it's an elegant solution to an end stage renal disease conundrum of longstanding: with the one-two punch of its steep financial costs and the physical exhaustion emerging from treatment, working is often not an option, and many patients exhaust savings or go deeply into debt to maintain their private healthcare insurance policies. As a function of that, AKF's HIPP pays its recipients monthly insurance premiums for the duration of their dialysis treatment.
For the latter, mostly insurance companies offering healthcare to the public, HIPP is a financial headache of a scale eclipsed only by its sheer evil brilliance."
“No one is saying that the AKF or its policies are all bad,” she said, “but [the fund] is [incentivized] to expand clinic-centered dialysis. The large dialysis organizations, who give the fund most of its money, are the obvious beneficiaries.”